Analysis on changes of gut microbiota in children with autism spectrum disorder based on high-throughput sequencing

doi:10.3969/j.issn.1673-8640.2021.02.007

Abstract

Abstract:

Objective To investigate the changes of gut microbiota in children with autism spectrum disorders（ASD）. Methods A total of 35 children with ASD were enrolled into ASD group,and 35 healthy children were assigned to healthy control group. Genomic DNA was extracted from fecal samples,and Illumina sequencing platform was used for sequencing analysis to determine the characteristics of gut microbiota. Results There was difference in gut microbiota between ASD and healthy control groups. At the phylum level,there was no significant difference in the relative abundance of the Firmicutes,Bacteroidetes,Proteobacteria or Actinobacteria（P>0.05）. There was a significant difference in the structure of Candidatus Saccharibacteria between the 2 groups（P=0.01）,but the relative abundance in the structure of gut microbiota was very low. At the genus level,there were significant differences in the relative abundance of Subdoligranulum,Holdemania,Candidatus Saccharibacteria noname,Prevotella,Burkholderiales noname,Gordonibacter,Alistipes,Solobacterium,Parasutterella,Anaerotruncus,Aggregatibacter,Comamonas,Gemella and Granulicatella between the 2 groups（P<0.05）. Further analysis of gut microbiota showed that the relative abundance of Alistipes onderdonkii,Alistipes putredinis,Bacteroides finegoldii,Alistipes shahii,Streptococcus vestibularis,Holdemania filiformis,Bacteroides massiliensis,Burkholderiales bacterium-1-1-47,Megamonas funiformis,Parabacteroides merdae,Ruminococcus flavefaciens,Lachnospiraceae bacterium_3_1_57FAA_CT1 and Parasutterella excrementihominis in ASD group were higher than those in healthy control group,but the relative abundance of Granulicatella adiacens,Fusobacterium mortiferum,Solobacterium moorei,Eubacterium rectale,Candidate division_TM7_single_cell_isolate_TM7c and Gemella morbillorum in the ASD froup were lower than those in the healthy control group（P<0.05）. Conclusion Intestinal microecological disorders exist in ASD children,but ASD children do not have a specific intestinal microbial composition.

Key words: Gut microbiota, High-throughput sequencing, Autism spectrum disorder

CLC Number:

R372

ZENG Peipei, ZENG Ting, DENG Liangqiong, GUO Hao, FENG Yushan, HUANG Liping, LI Honghui. Analysis on changes of gut microbiota in children with autism spectrum disorder based on high-throughput sequencing[J]. Laboratory Medicine, 2021, 36(2): 153-161.

Figures/Tables 10

References 24

[1]	LAI M C,LOMBARDO M V,BARON-COHEN S.Autism[J]. Lancet,2014,383(9920):896-910.
[2]	BAIO J,WIGGINS L,CHIRSTENSEN D L,et al.Prevalence of autism spectrum disorder among children aged 8-years -autism and developmental disabilities monitoring network,11 sites,United States,2014[J]. MMWR Surveill Summ,2018,67(6):1-23.
[3]	孔维廷,王瑜. 肠道菌群与孤独症谱系障碍的研究进展[J]. 中国儿童保健杂志,2019,27(4):407-410.
[4]	KULTIMA J R,COELHO L P,FORSLUND K,et al.Mocat2:a metagenomic assembly,annotation and profiling framework[J]. Bioinformatics,2016,32(16):2520-2523.
[5]	ZHU W,LOMSADZE A,BORODOVSKY M.Ab initio gene identification in metagenomic sequences[J]. Nucleic Acids Res,2010,38(12):e132.
[6]	FU L,NIU B,ZHU Z,et al.CD-HIT:acceletated for clustering the next-generation sequencing data[J]. Bioinformatics,2012,28(23):3150-3152.
[7]	CLARKE K R.Non-parametric multivariate analyses of changes in community structure[J]. Aust J Ecol,1993,18(1):117-143.
[8]	WARTON D I,WRIGHT S T,YI W.Distance-based multivariate analyses confound location and dispersion effects[J]. Methods Ecol Ev,2012,3(1):89-101.
[9]	COHEN LJ,ESTERHAZY D,KIM SH,et al.Commensal bacteria make GPCR ligands that mimic human signalling molecules[J]. Nature,2017,549(7670):48-53.
[10]	KELLY J R,MINUTO C,CRYAN J F,et al.Cross talk:the microbiota and neurodevelopmental disorders[J]. Front Neurosic,2017,11:490.
[11]	SLATTERY J,MACFABE D F,FRYE R E.The significance of the enteric microbiome on the development of childhood disease:a review of prebiotic and probiotic therapies in disorders of childhood[J]. Clin Med Insights Pediatr,2016,10:91-107.
[12]	GHAISAS S,MAHER J,KANTHASAMY A.Gut microbiome in health and disease:lingking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative disease[J]. Pharmacol Ther,2016,158:52-62.
[13]	SHARON G,CRUZ N J,KANG D W,et al.Human gut microbiota from autism spectrum disorder promote behavioral symptoms in mice[J]. Cell,2019,177(6):1600-1618.
[14]	CORETTI L,PAPARO L,RICCIO M P,et al.Gut microbiota features in young children with autism spectrum disorders[J]. Front Microbiol,2018,9:3146.
[15]	STRATI F,CAVALIERI D,ALBANESE D,et al.New evidences on the altered gut microbiota in autism spectrum disorders[J]. Microbiome,2017,5(1):24.
[16]	MARÍNEZ-GONZÁLEZ A E,ANDREO-MARTINEZ P. The role of gut microbiota in gastrointestinal symptoms of children with ASD[J]. Medicina(Kaunas),2019,55(8):408-422.
[17]	ZHANG M,MA W,ZHANG J,et al.Analysis of gut microbiota profiles and microbe-disease associations in children with autismspectrum disorders in China[J]. Sci Rep,2018,8(1):13981.
[18]	MA B,LIANG J,DAI M,et al.Altered gut microbiota in Chinese children with autism spectrum disorders[J]. Front Cell Infect Microbiol,2019,9:40.
[19]	FATTORUSSO A,DI GENOVA L,DELL'ISOLA G B,et al. Autism spectrum disorders and the gut microbiota[J]. Nutrients,2019,11(3):521.
[20]	TAKENAKA R,AOI Y,OZAKI N,et al.Specificities and efficiencies of primers targeting candidatus phylum saccharibacteria in activated sludge[J]. Materials(Basel),2018,11(7):1129.
[21]	LANKELMA J M,BIRNIE E,WEEHUIZEN T A F,et al. The gut microbiota as a modulator of innate immunity duning melioidosis[J]. PLoS Negl Trop Dis,2017,11(4):e0005548.
[22]	WEI Y,YANG J,WANG J,et al.Successful treatment with fecal microbiota transplantation in patient with multiple organ dysfunction syndrome and diarrhea following severe sepsis[J]. Crit Care,2016,20(1):332.
[23]	SCHUIJT T J,LANKELMA J M,SCICLUNA B P,et al.The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia[J]. Gut,2016,65(4):575-583.
[24]	NING Q,LIU Z,WANG X,et al.Neurodegenerative change and neuroapoptosis induced by systemic lipopolysaccharide administration are reversed by dexmedetomidine treatment in mice[J]. Neurol Res,2017,39(4):357-366.

组别	罕见小球菌属	霍尔德曼菌属	Candidatus Saccharibacteria noname属	普雷沃菌属	Burkholderiales noname属	戈登杆菌属	另枝菌属
ASD组	2.08	0.04	0.002	3.61	0.09	0.012	6.34
正常对照组	0.74	0.02	0.009	3.39	0.04	0.01	2.44
统计值	842.0	827.0	471.0	814.0	802.0	800.0	808.0
P值	0.007	0.008	0.017	0.018	0.018	0.02	0.022
组别	Solobacterium属	Parasutterella属	Anaerotruncus属	杆菌属	丛毛单胞菌属	孪生球菌属	颗粒球菌属
ASD组	0.001	0.14	0.16	0	0.001	0.012	0.012
正常对照组	0.002	0.05	0.09	0.001	0	0.03	0.04
统计值	469.5	793.0	785.0	542.5	682.5	444.0	444.0
P值	0.022	0.03	0.042	0.042	0.042	0.046	0.048

组别	罕见小球菌属	霍尔德曼菌属	Candidatus Saccharibacteria noname属	普雷沃菌属	Burkholderiales noname属	戈登杆菌属	另枝菌属
ASD组	2.08	0.04	0.002	3.61	0.09	0.012	6.34
正常对照组	0.74	0.02	0.009	3.39	0.04	0.01	2.44
统计值	842.0	827.0	471.0	814.0	802.0	800.0	808.0
P值	0.007	0.008	0.017	0.018	0.018	0.02	0.022
组别	Solobacterium属	Parasutterella属	Anaerotruncus属	杆菌属	丛毛单胞菌属	孪生球菌属	颗粒球菌属
ASD组	0.001	0.14	0.16	0	0.001	0.012	0.012
正常对照组	0.002	0.05	0.09	0.001	0	0.03	0.04
统计值	469.5	793.0	785.0	542.5	682.5	444.0	444.0
P值	0.022	0.03	0.042	0.042	0.042	0.046	0.048

组别	翁德顿氏另枝菌		Alistipes putredinis		毗邻颗粒链球菌		芬戈尔德氏拟杆菌	谢氏另枝菌	前庭链球菌	死亡梭杆菌	丝状霍尔德曼菌	芽胞拟杆菌	伯克霍尔德菌-1-1-47
ASD组	1.636		3.699		0.002		0.290	0.679	0.025	0.032	0.028	1.665	0.095
正常对照组	0.150		1.686		0.006		0.037	0.187	0.004	0.557	0.007	0.681	0.037
统计值	915.0		849.0		415.0		811.0	821.0	784.0	452.0	786.5	814.0	802.0
P值	0.000 2		0.005		0.008		0.009	0.011	0.013	0.014	0.016	0.017	0.018
组别	单形巨单胞菌	Gordonibacter pamelaeae	粪副拟杆菌	生黄瘤胃球菌		莫氏细小杆菌	毛螺科菌_3_1_ 57FAA_CT1	Parasutterella excrementihominis		直肠真杆菌	Candidate division_TM7_single_cell_isolate_TM7c		麻疹孪生球菌
ASD组	0.212	0.018	1.068	0.008 0		0.001	0.045	0.139		2.549	0.001		0.000 3
正常对照组	0.120	0.007	0.886	0.000 3		0.002	0.011	0.049		5.018	0.006		0.004 0
统计值	785.0	800.0	807.5	737.0		469.5	780.5	793.0		794.0	488.0		488.0
P值	0.019	0.020	0.020	0.021		0.023	0.026	0.030		0.032	0.032		0.032

组别	翁德顿氏另枝菌		Alistipes putredinis		毗邻颗粒链球菌		芬戈尔德氏拟杆菌	谢氏另枝菌	前庭链球菌	死亡梭杆菌	丝状霍尔德曼菌	芽胞拟杆菌	伯克霍尔德菌-1-1-47
ASD组	1.636		3.699		0.002		0.290	0.679	0.025	0.032	0.028	1.665	0.095
正常对照组	0.150		1.686		0.006		0.037	0.187	0.004	0.557	0.007	0.681	0.037
统计值	915.0		849.0		415.0		811.0	821.0	784.0	452.0	786.5	814.0	802.0
P值	0.000 2		0.005		0.008		0.009	0.011	0.013	0.014	0.016	0.017	0.018
组别	单形巨单胞菌	Gordonibacter pamelaeae	粪副拟杆菌	生黄瘤胃球菌		莫氏细小杆菌	毛螺科菌_3_1_ 57FAA_CT1	Parasutterella excrementihominis		直肠真杆菌	Candidate division_TM7_single_cell_isolate_TM7c		麻疹孪生球菌
ASD组	0.212	0.018	1.068	0.008 0		0.001	0.045	0.139		2.549	0.001		0.000 3
正常对照组	0.120	0.007	0.886	0.000 3		0.002	0.011	0.049		5.018	0.006		0.004 0
统计值	785.0	800.0	807.5	737.0		469.5	780.5	793.0		794.0	488.0		488.0
P值	0.019	0.020	0.020	0.021		0.023	0.026	0.030		0.032	0.032		0.032

组别	K08856	K02319	K04464	K06322	K09385	K09628	K09655	K12444	K12688	K13003
ASD组	9.257	90.714	20.571	50.829	22.600	15.257	38.200	78.343	4.429	24.514
正常对照组	109.657	1.000	7.457	4.571	1.771	5.257	7.543	11.143	62.257	2.257
P值	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
组别	K14446	K14819	K16323	K17916	K18563	K18663	K19562	K20891	K21285	K21559
ASD组	21.429	46.457	23.543	30.200	21.829	1.971	1.143	23.886	35.800	60.286
正常对照组	4.629	4.171	4.371	91.114	1.600	17.743	178.400	1.343	2.743	17.829
P值	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00